{
    "2021-06-07": [
        [
            {
                "time": "2023-10-01",
                "original_text": "Biotech Shares Soar as Biogen Drug Approval Stokes Optimism",
                "features": {
                    "keywords": [
                        "Biotech",
                        "Shares",
                        "Soar",
                        "Biogen",
                        "Drug",
                        "Approval",
                        "Optimism"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotech",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Why Eli Lilly Stock Soared Today",
                "features": {
                    "keywords": [
                        "Eli",
                        "Lilly",
                        "Stock",
                        "Soared",
                        "Today"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Job Openings, Business Optimism, Crude Stockpile: 3 Things to Watch",
                "features": {
                    "keywords": [
                        "Job",
                        "Openings",
                        "Business",
                        "Optimism",
                        "Crude",
                        "Stockpile"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "economy",
                        "energy"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Novo Nordisk (NVO) Semaglutide Gets FDA Nod for Obesity",
                "features": {
                    "keywords": [
                        "Novo",
                        "Nordisk",
                        "Semaglutide",
                        "FDA",
                        "Nod",
                        "Obesity"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Eli Lilly Pops On Hope For Approval To Alzheimer’s Therapy",
                "features": {
                    "keywords": [
                        "Eli",
                        "Lilly",
                        "Pops",
                        "Hope",
                        "Approval",
                        "Alzheimer’s",
                        "Therapy"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "5 Top Stock Gainers for Monday: U.S. Concrete, Moderna, Eli Lilly",
                "features": {
                    "keywords": [
                        "Top",
                        "Stock",
                        "Gainers",
                        "U.S.",
                        "Concrete",
                        "Moderna",
                        "Eli",
                        "Lilly"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "construction",
                        "biotech",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}